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WHAT DO WE KNOW?
 
Chronic airway inflammation is a general feature of some types
of asthma, cystic fibrosis (CF), bronchopulmonary dysplasia
(BPD), and chronic obstructive pulmonary disease (COPD).
This chronic inflammation is associated with structural
changes in the airway wall and parenchyma, which affect the
functional properties of these tissues. It is these changes that
are defined as remodeling. However, association between in-
flammation and remodeling cannot be regarded as proof of
causality. These airway changes should not be considered as
fixed; there is a dynamic state of cell and matrix protein turn-
over in both diseased and healthy airways. Knowledge of the
type and distribution of morphological changes that can (ir)re-
versibly impair lung function may potentially lead to the de-
velopment of more effective treatment. Unfortunately, virtu-
ally all our knowledge comes from studies of the mature airway.
We do not know whether in children the response of cells to
inflammatory stimuli is greater or less than in adults, or the ca-
pacity of the developing airway to restore itself to normality.
 
Lung Morphology
 
The morphological development of the lungs from the simple
outgrowths of the primitive foregut to the mature adult struc-
tures is well described (1). The mechanisms controlling these
processes and the growth factors involved are less well charac-
terized, and in general a reductionist approach to describe sin-
gle processes rather than synthesis of a complex whole is all
that has been attempted. The context of lung development is
an important one. It should be noted that many growth factors
play an important part in the inflammatory and remodeling
process (2). Furthermore, steroid treatment, which may have a
beneficial effect on airway remodeling (3), may have an ad-
verse effect on the developing lung. The profound morpholog-
ical changes that occur during development have important
functional consequences. Since airway mechanics change with
growth and development, the functional consequences of re-
modeling will be age dependent (4).
The morphology of the airways and parenchyma has been
established in normal lungs, in the lungs of patients with air-
way disease, and in animal models of airway disease. For this
review, nomenclature is used to quantify subdivisions of the
bronchial wall as seen in histological cross-sections (5) (Figure
1 [6]). Changes in various components of the bronchial wall in
asthma, CF, BPD, and COPD will be addressed, going from
the epithelium to the outer wall area and parenchyma.
 
Epithelium
 
The surface area of the airway is covered with pseudostratified
ciliated epithelium. The respiratory epithelial forms an inter-
active interface between the external and the internal environ-
ment and has many important functions, which include (7) the
following:
• Formation of a natural barrier to invasion and injury by bac-
teria, viruses, and toxic inhaled molecules
• Contribution to the mucociliary clearance of inhaled matter
• Formation of a barrier against leakage of solutes in the air-
ways
• Modulation of bronchial smooth muscle tone by production
of mediators and neurotransmitters that reduce smooth
muscle tone, and by inactivation of factors that increase this
tonus
In asthma, shedding of epithelium is seen in bronchoalveo-
lar lavage (BAL) fluid of children and adults (8, 9). Damage of
the airway surface epithelium is prominent in biopsies of
adults with (mild) asthma (10). The importance of epithelial
loss and its distribution in the bronchial tree in children with
asthma are unknown. Twenty-three percent of the airway sur-
face area was not covered by epithelium in patients with CF
who underwent lung transplantation (11). It has been shown
that 
 
Pseudomonas aeruginosa
 
 preferentially adheres to regen-
erating respiratory epithelium (12). The large airways of in-
fants with BPD who have died show substantial loss of epithe-
lium, up to 50% of the surface area (13). The loss in smaller
airways varies between 1 and 25% (14, 15). Increased shed-
ding of the epithelium in BAL fluid has been described for pa-
tients with COPD. However, lobectomy specimens from these
patients show only 9% loss of epithelium (11). The height of
the epithelium in the smaller airways of patients with CF and
patients with BPD is increased, which is likely to increase the
resistance of the peripheral airways.
 
Basement Membrane
 
The epithelial layer rests on the basement membrane, which
consists of two layers (16): the basal lamina, which can be seen
only by electron microscopy, and the lamina reticularis, which
can be seen by light microscope and consists of a loose array of
collagen fibrils that are connected to the smooth muscle and
adventitial layer. The mechanical properties of the basement
membrane are thought to be an important determinant for the
stiffness and folding pattern of the mucosa during contraction
of bronchial smooth muscle (17, 18). Extensive thickening of
the basement membrane has been described in asthma and
can be seen in early stages of the disease (3, 19–21). Bronchial
myofibroblasts are thought to be responsible for this thicken-
ing (22). In CF subepithelial fibrosis of central airways has been
described in biopsy and lobectomy material (23). Whether the
basement membrane is thickened by BPD has not been sys-
tematically investigated to our knowledge. 
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Inner Airway Wall
 
The tissue between the basement membrane and smooth mus-
cle layer contains a dense microvascular network that occupies
4 to 10% of the inner wall, and that is embedded in fibrous tis-
sue (24). Thickening of the inner airway wall is a common fea-
ture of asthma, CF, BPD, and COPD (6, 11, 14, 25). The mag-
nitude of the thickening is greatest in patients with asthma or
CF (11). In COPD, the thickening of the inner airway wall
area is in proportion to the inflammatory changes and is corre-
lated with the level of airflow obstruction (6). In asthma, CF,
and COPD, thickening is more severe in peripheral compared
with more central airways (6, 11, 25). Increased microvascular
permeability and plasma exudation are likely to contribute to
this airway wall thickening (26–28). The absolute number of
blood vessels in patients who have died from or with asthma is
increased in proportion to the increase in airway wall area (29).
 
Smooth Muscle
 
The smooth muscle layer runs down from the trachea to the
smallest bronchioles. Smooth muscle makes up 5 to 10% of
the bronchial wall of the small airways and only 1 to 2% of the
more central airways (6, 30). The amount of smooth muscle in
adults with (fatal) asthma is increased (25, 31). However, it is
not clear whether the increased smooth muscle mass is accom-
panied by an increase in force (32). The effect of an increase in
smooth muscle force is further amplified by airway wall thick-
ening (11, 31). The amount of bronchial smooth muscle is in-
creased in CF, BPD, and in the small airways of patients with
COPD (11, 14, 25, 33). The proportional increase in bronchial
smooth muscle is higher in more peripheral airways compared
with central airways.
 
Cartilage
 
Airway cartilage is a prominent component of the outer wall
area and makes up 25 to 63% of the total wall in large airways
and 4 to 10% in smaller airways. This cartilage is an important
structural contributor to the ability of the airway wall to resist
deformation during forced expiration. The biochemical com-
position and biomechanical properties of cartilage change
with age (34, 35). Some studies of patients with COPD have
suggested that inflammation reduces cartilage volume and,
therefore, contributes to increased airflow obstruction (36, 37).
This was not confirmed in other studies (38, 39). In patients
with CF the cartilage volume is reduced in comparison with
patients with COPD (11). Patients with asthma and COPD show
more degeneration and perichondrial fibrosis compared with
control subjects (39).
 
Outer Wall
 
The outer wall area is the tissue between the outer edge of the
smooth muscle layer and the parenchyma, with which it forms
a continuum. This area is, therefore, difficult to measure. In-
flammatory thickening of the outer wall area can theoretically
uncouple airway smooth muscle from the tethering forces of
the parenchyma and thus contribute to airway narrowing (32).
Little is known about the changes in the outer wall in relation
to chronic airway inflammation. Probably, the outer wall area
is thickened in severe asthma (25) and BPD (14). For COPD
this is less clear (6, 30).
 
Parenchyma
 
There is a strong functional interdependence between lung pa-
renchyma and airways. Alveolar walls attach to the outside of
the intraparenchymal airways and contain elastic fibers that
resist deformation and provide radial traction on the airway
wall. Loss of this functional interdependence can lead to ab-
normal smooth muscle mechanics (32, 40). In adults with
asthma it has been shown that considerable alveolar tissue in-
flammation is present that contributes to lung function abnor-
malities in these patients (41). In patients with COPD severe
airflow obstruction is related to destruction of peribronchial
alveoli (42), reduced density of the lung parenchyma (43), and
a larger distance between alveolar attachments (44). It is likely
that airways in emphysematous lungs are irregular and dis-
torted (45, 46). A reduction in the number of alveoli is a possi-
ble feature of CF (47) and is a common feature in BPD (48, 49).
 
WHAT DO WE NEED TO KNOW?
 
1.
 
 What structural abnormalities are present in the lungs of
children in different age groups?
 
2.
 
 Lung growth is a highly complex process. Depending on
the severity and timing of disturbances in lung growth, a vari-
ety of permanent or transient pathological conditions may re-
sult. However, little is known about how airway inflammation
interferes with lung growth (1) or whether the morphological
changes are secondary to inflammation. Using available data,
it is not possible to ascertain whether inflammation precedes
the airway structural features conventionally labeled as re-
modeling, or whether in fact some or all of the airway struc-
tural changes are independent of, or even precede, inflamma-
tion. Therefore, we need to know whether prenatal pulmonary
inflammation, which is usually associated with infection or am-
nionitis, is important in any subsequent airway changes (50).
 
3.
 
 Most of the literature on airway remodeling is based on
adult patients with COPD since lung tissue from patients op-
erated on for a lung tumor is relatively easily available. Con-
siderably less is known about remodeling in the lungs of pa-
tients with asthma, CF, or BPD since the lung tissue of these
patients is difficult to obtain. Morphometric studies should in-
clude the whole range from large airways and parenchyma.
Data obtained from central airways may have only little rele-
vance for disease processes in more peripheral airways (6, 51).
Treatment of chronic airway disease in children should prima-
rily prevent or reduce remodeling in those areas of the lung re-
sponsible for impairment of lung function. Identification of
this area enables us to select the most effective aerosol charac-
teristics of the drug of choice. For example, an aerosol with a
small median particle size is likely to be more effective in
Figure 1. Diagram of airway wall dimensions (6). [Reproduced with
permission from Tiddens, H. A. W. M., P. D. Paré, J. C. Hogg, W. C. J.
Hop, R. Lambert, and J. C. de Jongste. Am. J. Respir. Crit. Care Med.
152:260–266.]
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small airways than an aerosol with larger particles. To date it
is still difficult to define the most important target area of the
bronchial tree for more selective treatment for a number of
reasons. First, for children only limited data are available on
the distribution of morphological abnormalities along the
bronchial tree (11, 14). Second, although morphological
changes of airways and parenchyma have been described, lit-
tle is known about how these changes affect their mechanical
properties and lead to lung function abnormalities (52). Third,
little is known about the (ir)reversibility of various morpho-
logical changes. For example, thickening of the basement
membrane might be reversible, as was suggested by biopsy
findings of a prospective study of patients with asthma treated
with inhaled corticosteroids for 2 yr (3). To date, we do not
know the extent of the reversibility of any structural changes
in children.
 
HOW DO WE ACHIEVE THIS?
 
1.
 
 To define structural abnormalities in the lungs of pa-
tients in different age groups, comparison with normal tissue is
crucial. Furthermore, morphometric data on normal lungs are
essential to study the effect of structural and functional changes
of airways and parenchyma on lung function in computer
models (6, 11, 53). Such models are available for adults based
on “normal” lung geometry derived from cast studies (54).
These models can be modified for children when pediatric
lung geometry data are available.
 
2.
 
 The normal geometry of the lung should be described us-
ing post-mortem casts and modern imaging techniques, such
as three-dimensional computer tomography and magnetic res-
onance imaging, in healthy and diseased children in different
age groups (55–60).
 
3.
 
 Animal models of chronic airway inflammation during
growth can be used to determine how airway inflammation in-
terferes with lung growth (61, 62).
 
4.
 
 Lung function measurements could be used to study the
relationship between chronic inflammation and airway me-
chanics in a noninvasive fashion in children. For example, high-
frequency respiratory input impedance measurements (63)
could be used to estimate airway compliance, or the effect of
deep breaths on flow volume estimates of airway obstruction
could be used to detect abnormal parenchyma–airway interde-
pendence (64, 65).
 
5.
 
 We need imaging techniques that do not use ionizing ra-
diation and that can be applied serially to measure lung growth.
These techniques are essential if we are to follow the struc-
tural outcomes of interventions, particularly in a context where
intervention could harm other parts of the growing lung.
 
6.
 
 Systematic collection of autopsy material and from chil-
dren who have had a lobar resection or pneumonectomy in
designated centers is needed to obtain further knowledge of
the morphology of diseased lungs.
 
7.
 
 Wherever possible, indirect techniques should be vali-
dated against biopsy information on structure. Every ethical
opportunity to obtain biopsy material from young children
should be sought.
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